| Page 1777 | Kisaco Research
 

Madhusudan Peshwa

Global Head of R&D for Cell & Gene Therapy
GE

Madhusudan Peshwa

Global Head of R&D for Cell & Gene Therapy
GE

Madhusudan Peshwa

Global Head of R&D for Cell & Gene Therapy
GE
 

Dawn Driscoll

CEO
Cell Therapies

Dawn Driscoll

CEO
Cell Therapies

Dawn Driscoll

CEO
Cell Therapies
 

Andrew Griffiths

Head of Value Chain Sustainability
Nestlé UK&I, CEnv, FIEMA, CEng, MIET

Andrew Griffiths

Head of Value Chain Sustainability
Nestlé UK&I, CEnv, FIEMA, CEng, MIET

Andrew Griffiths

Head of Value Chain Sustainability
Nestlé UK&I, CEnv, FIEMA, CEng, MIET
 

Dr. Alexandre Juillerat

Laboratory Head
Cellectis

Dr. Alexandre Juillerat

Laboratory Head
Cellectis

Dr. Alexandre Juillerat

Laboratory Head
Cellectis
 

Dr. Leon Song

Director for Business Development, Biologics Development Business Unit
GenScript

Dr. Leon Song

Director for Business Development, Biologics Development Business Unit
GenScript

Dr. Leon Song

Director for Business Development, Biologics Development Business Unit
GenScript
 

Jim Totty

Managing Partner
Earth Capital

Jim has been an investor in sustainability focussed companies and infrastructure for 20 years, after a prior career in advisory and academia. He has worked in sectors such as FMCG, Agriculture, Pollution Remediation and Logistics. Jim was previously at PricewaterhouseCoopers, Citigroup and Earth Capital. He holds a PhD from Imperial College London and is a Chartered Financial Analyst.

Jim Totty

Managing Partner
Earth Capital

Jim Totty

Managing Partner
Earth Capital

Jim has been an investor in sustainability focussed companies and infrastructure for 20 years, after a prior career in advisory and academia. He has worked in sectors such as FMCG, Agriculture, Pollution Remediation and Logistics. Jim was previously at PricewaterhouseCoopers, Citigroup and Earth Capital. He holds a PhD from Imperial College London and is a Chartered Financial Analyst.

 

Bridget Croke

VP, External Affairs
Closed Loop Partners

Bridget Croke leads external affairs including investor partnerships, industry partnerships, communications and special projects at the Closed Loop Partners. Bridget has been been working on sustainability, circular economy and turning waste into value for 20 years through organizations including Fair Food Project of Philadelphia, Recyclebank and Purpose before Closed Loop Partners

Bridget Croke

VP, External Affairs
Closed Loop Partners

Bridget Croke

VP, External Affairs
Closed Loop Partners

Bridget Croke leads external affairs including investor partnerships, industry partnerships, communications and special projects at the Closed Loop Partners. Bridget has been been working on sustainability, circular economy and turning waste into value for 20 years through organizations including Fair Food Project of Philadelphia, Recyclebank and Purpose before Closed Loop Partners

 

Dr. Otgonchimeg (Oti) Rentsendorj

Staff Fellow
Cosmetics Division, Office of Cosmetics and Colors at United States Food and Drug Administration

Dr. Otgonchimeg Rentsendorj is a Staff Fellow, Biologist-Microbiologist. She specializes in cosmetic ingredients safety reviews, contributes in regularly, compliance, and communications fields. She also provides expertise and guidance in in vitro/in vivo research/review projects. Oti received her Master’s in Microbiology from Kazan Federal University, Russia, and her Ph.D. in Molecular Biology from Hungarian Academy of Sciences, Hungary. She has 4 years of FDA research/regulatory experience and 10 years of academic experience at JHU School of Medicine.

Dr. Otgonchimeg (Oti) Rentsendorj

Staff Fellow
Cosmetics Division, Office of Cosmetics and Colors at United States Food and Drug Administration

Dr. Otgonchimeg (Oti) Rentsendorj

Staff Fellow
Cosmetics Division, Office of Cosmetics and Colors at United States Food and Drug Administration

Dr. Otgonchimeg Rentsendorj is a Staff Fellow, Biologist-Microbiologist. She specializes in cosmetic ingredients safety reviews, contributes in regularly, compliance, and communications fields. She also provides expertise and guidance in in vitro/in vivo research/review projects. Oti received her Master’s in Microbiology from Kazan Federal University, Russia, and her Ph.D. in Molecular Biology from Hungarian Academy of Sciences, Hungary. She has 4 years of FDA research/regulatory experience and 10 years of academic experience at JHU School of Medicine. Her background is in microbiology, cellular/molecular biology, and bioinformatics, has ˃50 peer-reviewed papers and abstracts.